Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Capital Employed (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Return on Capital Employed for 6 consecutive years, with 0.44% as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Return on Capital Employed rose 19.0% year-over-year to 0.44%, compared with a TTM value of 0.44% through Sep 2019, up 19.0%, and an annual FY2018 reading of 0.61%, down 13.0% over the prior year.
  • Return on Capital Employed was 0.44% for Q3 2019 at Larimar Therapeutics, down from 0.41% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.26% in Q2 2015 and bottomed at 0.75% in Q2 2018.
  • Average Return on Capital Employed over 5 years is 0.48%, with a median of 0.5% recorded in 2017.
  • The sharpest move saw Return on Capital Employed decreased -25bps in 2018, then skyrocketed 34bps in 2019.
  • Year by year, Return on Capital Employed stood at 0.41% in 2015, then dropped by -13bps to 0.46% in 2016, then dropped by -24bps to 0.57% in 2017, then rose by 5bps to 0.54% in 2018, then rose by 18bps to 0.44% in 2019.
  • Business Quant data shows Return on Capital Employed for LRMR at 0.44% in Q3 2019, 0.41% in Q2 2019, and 0.57% in Q1 2019.